Skip to main content

Advertisement

SpringerLink
Log in

Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kundra P, Burman KD (2012) The effect of medications on thyroid function tests. Med Clin N Am 96(2):283–295

    Article  PubMed  CAS  Google Scholar 

  2. Ho NA, Schmidt RE, Behrens G (2010) HIV-therapy-associated immune reconstitution syndrome presenting as immunogenic hyperthyroidism. Dtsch Med Wochenschr 135(23):1171–1174

    Article  PubMed  CAS  Google Scholar 

  3. Visser R, de Mast Q, Netea-Maier RT, van der Ven AJ (2012) Hashimoto’s thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus-seropositive patient. Thyroid 22(8):853–855

    Article  PubMed  CAS  Google Scholar 

  4. O’Connor PW, Goodman A, Kappos L et al (2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 76(22):1858–1865

    Article  PubMed  Google Scholar 

  5. Tan IL, McArthur JC, Clifford DB, Major EO, Nath A (2011) Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 77(11):1061–1067

    Article  PubMed  CAS  Google Scholar 

  6. Kappos L, Bates D, Edan G et al (2011) Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol 10(8):745–758

    Article  PubMed  CAS  Google Scholar 

  7. Polman CH, Kappos L, Dahlke F et al (2005) European Study Group on interferon beta-1b in SPMS. Interferon beta-1b treatment does not induce autoantibodies. Neurology 64(6):996–1000

    Article  PubMed  CAS  Google Scholar 

  8. Marazuela M, Postigo AA, Acevedo A et al (1994) Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves’ and Hashimoto’s thyroid glands. Eur J Immunol 24(10):2483–2490

    Article  PubMed  CAS  Google Scholar 

  9. Nakashima M, Eguchi K, Ida H et al (1994) The expression of adhesion molecules in thyroid glands from patients with Graves’ disease. Thyroid 4(1):19–25

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Clara Alfaro-Cervelló, MD, PhD, has contributed in editing the manuscript for non-intellectual content. Pluchino Lab Post doctoral fellow., Dept of Clinical Neurosciences, Cambridge Centre for Brain Repair and Stem Cell Institute, University of Cambridge. Christopher Kellett, Philologist, has contributed in editing the manuscript for non-intellectual content.

Author information

Authors and Affiliations

  1. Multiple Sclerosis Unit, Department of Neurology, Hospital General Universitario de Valencia, Valencia, Spain

    María Carcelén-Gadea & Angeles Cervelló Donderis

  2. Fundación Investigación Hospital General Universitario, Valencia, Spain

    María Carcelén-Gadea & Angeles Cervelló Donderis

  3. Department of Endocrinology, Hospital General Universitario de Valencia, Valencia, Spain

    Juan Carlos Ferrer-Garcia

Authors
  1. María Carcelén-Gadea
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Carlos Ferrer-Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angeles Cervelló Donderis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to María Carcelén-Gadea.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carcelén-Gadea, M., Ferrer-Garcia, J.C. & Cervelló Donderis, A. Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis. Neurol Sci 34, 2259–2261 (2013). https://doi.org/10.1007/s10072-013-1497-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-013-1497-3

Keywords

Search

Navigation